Penumbra, Inc. (PEN): are the analysts right?

Jun 11, 26

■ Sector Perform neutral · not a buy · 🎯$374

Price at call : $318.71 — gap to target +17%

Today : $316.33 — gap to target +18%

🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)

in progress (365j)
matures : Jun 11, 27

May 7, 26

■ Neutral neutral · not a buy · 🎯$350

Price at call : $322.23 — gap to target +9%

Today : $316.33 — gap to target +11%

🎯 on PEN : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)

in progress (365j)
matures : May 7, 27

May 7, 26

▲ Outperform · 🎯$335

Price at call : $322.23 — upside +4%

Today : $316.33 — upside +6%

🎯 on PEN : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)

in progress (365j)
matures : May 7, 27

Feb 26, 26

▲ Outperform · 🎯$360

Price at call : $344.39 — upside +5%

Today : $316.33 — upside +14%

🎯 on PEN : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)

in progress (365j)
matures : Feb 26, 27

Jan 20, 26

■ Sector Perform neutral · not a buy · 🎯$374

Price at call : $357.68 — gap to target +5%

Today : $316.33 — gap to target +18%

🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)

in progress (365j)
matures : Jan 20, 27

Jan 20, 26

■ Hold neutral · not a buy · 🎯$374

Price at call : $355.44 — gap to target +5%

Today : $316.33 — gap to target +18%

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)

in progress (365j)
matures : Jan 20, 27

Jefferies ↗

Jan 16, 26

■ Hold neutral · not a buy · 🎯$374

Price at call : $355.44 — gap to target +5%

Today : $316.33 — gap to target +18%

🎯 on PEN : no call matured yet · 📊 on Health : 48% · +9.7% (98 calls)

in progress (365j)
matures : Jan 16, 27

Jan 16, 26

■ Hold neutral · not a buy

🎯 on PEN : no call matured yet · 📊 on Health : 45.5% · +1.8% (134 calls)

in progress (365j)
matures : Jan 16, 27

Jan 16, 26

■ Neutral neutral · not a buy · 🎯$374

Price at call : $350.78 — gap to target +7%

Today : $316.33 — gap to target +18%

🎯 on PEN : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)

in progress (365j)
matures : Jan 16, 27

Leerink Partners ↗

Jan 16, 26

■ Market Perform neutral · not a buy · 🎯$374

Price at call : $350.78 — gap to target +7%

Today : $316.33 — gap to target +18%

🎯 on PEN : 100% (1 call matured) · 📊 on Health : 44.4% · -4.7% (9 calls)

in progress (365j)
matures : Jan 16, 27

Baird ↗

Jan 16, 26

■ Neutral neutral · not a buy · 🎯$374

Price at call : $350.78 — gap to target +7%

Today : $316.33 — gap to target +18%

🎯 on PEN : 100% (1 call matured) · 📊 on Health : 48.6% · +2.9% (70 calls)

in progress (365j)
matures : Jan 16, 27

Jan 16, 26

■ Neutral neutral · not a buy · 🎯$349

Price at call : $350.78 — gap to target -1%

Today : $316.33 — gap to target +10%

🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 48.7% · +4.2% (39 calls)

in progress (365j)
matures : Jan 16, 27

Jan 16, 26

■ Hold neutral · not a buy · 🎯$374

Price at call : $350.78 — gap to target +7%

Today : $316.33 — gap to target +18%

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 62% · +8.5% (92 calls)

in progress (365j)
matures : Jan 16, 27

Jan 15, 26

■ Equal-Weight neutral · not a buy · 🎯$374

Price at call : $350.78 — gap to target +7%

Today : $316.33 — gap to target +18%

🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 46% · +2.8% (126 calls)

in progress (365j)
matures : Jan 15, 27

William Blair ↗

Jan 15, 26

■ Market Perform neutral · not a buy

🎯 on PEN : no call matured yet · 📊 on Health : 47.4% · +30.6% (19 calls)

in progress (365j)
matures : Jan 15, 27

B of A Securities ↗

Jan 5, 26

▲ Buy · 🎯$370

Price at call : $315 — upside +17%

Today : $316.33 — upside +17%

🎯 on PEN : 100% (1 call matured) · 📊 on Health : 61.4% · +19.8% (83 calls)

in progress (365j)
matures : Jan 5, 27

Dec 18, 25

▲ Buy · 🎯$370

Price at call : $315.9 — upside +17%

Today : $316.33 — upside +17%

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 62% · +8.5% (92 calls)

in progress (365j)
matures : Dec 18, 26

JP Morgan ↗

Dec 18, 25

▲ Overweight · 🎯$370

Price at call : $315.35 — upside +17%

Today : $316.33 — upside +17%

🎯 on PEN : 100% (1 call matured) · 📊 on Health : 48.4% · +4.8% (126 calls)

in progress (365j)
matures : Dec 18, 26

Dec 17, 25

▲ Buy · 🎯$359

Price at call : $315.35 — upside +14%

Today : $316.33 — upside +13%

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)

in progress (365j)
matures : Dec 17, 26

Dec 17, 25

▲ Buy · 🎯$388

Price at call : $309.26 — upside +25%

Today : $316.33 — upside +23%

🎯 on PEN : no call matured yet · 📊 on Health : 45.5% · +1.8% (134 calls)

in progress (365j)
matures : Dec 17, 26

Dec 11, 25

▲ Buy · 🎯$350

Price at call : $311.4 — upside +12%

Today : $316.33 — upside +11%

🎯 on PEN : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)

in progress (365j)
matures : Dec 11, 26

JP Morgan ↗

Nov 6, 25

■ Neutral neutral · not a buy · 🎯$275

Price at call : $266.19 — gap to target +3%

Today : $316.33 — gap to target -13%

🎯 on PEN : 100% (1 call matured) · 📊 on Health : 48.4% · +4.8% (126 calls)

in progress (365j)
matures : Nov 6, 26

Nov 6, 25

▲ Buy · 🎯$355

Price at call : $266.19 — upside +33%

Today : $316.33 — upside +12%

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)

in progress (365j)
matures : Nov 6, 26

Oct 27, 25

▲ Buy · 🎯$326

Price at call : $247.99 — upside +31%

Today : $316.33 — upside +3%

🎯 on PEN : no call matured yet · 📊 on Health : 45.5% · +1.8% (134 calls)

in progress (365j)
matures : Oct 27, 26

Oct 27, 25

▲ Buy · 🎯$320

Price at call : $247.99 — upside +29%

Today : $316.33 — upside +1%

🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 48.7% · +4.2% (39 calls)

in progress (365j)
matures : Oct 27, 26

Oct 15, 25

▲ Buy · 🎯$300

Price at call : $253.84 — upside +18%

Today : $316.33 — upside -5%

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 62% · +8.5% (92 calls)

in progress (365j)
matures : Oct 15, 26

Oct 8, 25

▲ Buy · 🎯$326

Price at call : $258.95 — upside +26%

Today : $316.33 — upside +3%

🎯 on PEN : no call matured yet · 📊 on Health : 45.5% · +1.8% (134 calls)

in progress (365j)
matures : Oct 8, 26

Oct 7, 25

▲ Outperform · 🎯$285

Price at call : $258.95 — upside +10%

Today : $316.33 — upside -10%

🎯 on PEN : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)

in progress (365j)
matures : Oct 7, 26

Sep 2, 25

▲ Outperform · 🎯$300

Price at call : $269.5 — upside +11%

Today : $316.33 — upside -5%

🎯 on PEN : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)

in progress (365j)
matures : Sep 2, 26

Morgan Stanley ↗

Jul 31, 25

■ Equal-Weight neutral · not a buy · 🎯$266

Price at call : $243.01 — gap to target +9%

Today : $316.33 — gap to target -16%

🎯 on PEN : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)

in progress (365j)
matures : Jul 31, 26

Jul 30, 25

▲ Buy · 🎯$310

Price at call : $252.27 — upside +23%

Today : $316.33 — upside -2%

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 62% · +8.5% (92 calls)

in progress (365j)
matures : Jul 30, 26

UBS ↗

Jul 30, 25

▲ Buy · 🎯$335

Price at call : $252.27 — upside +33%

Today : $316.33 — upside +6%

🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)

in progress (365j)
matures : Jul 30, 26

Jul 30, 25

▲ Outperform · 🎯$325

Price at call : $252.27 — upside +29%

Today : $316.33 — upside +3%

🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)

in progress (365j)
matures : Jul 30, 26

Baird ↗

Jul 30, 25

▲ Outperform · 🎯$285

Price at call : $252.27 — upside +13%

Today : $316.33 — upside -10%

🎯 on PEN : 100% (1 call matured) · 📊 on Health : 48.6% · +2.9% (70 calls)

in progress (365j)
matures : Jul 30, 26

Jul 30, 25

▲ Overweight · 🎯$290

Price at call : $252.27 — upside +15%

Today : $316.33 — upside -8%

🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 46% · +2.8% (126 calls)

in progress (365j)
matures : Jul 30, 26

Jul 30, 25

▲ Buy · 🎯$350

Price at call : $254.21 — upside +38%

Today : $316.33 — upside +11%

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)

in progress (365j)
matures : Jul 30, 26

Jul 9, 25

■ Neutral neutral · not a buy · 🎯$285

Price at call : $243.87 — gap to target +17%

Today : $316.33 — gap to target -10%

🎯 on PEN : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)

in progress (365j)
matures : Jul 9, 26

Apr 24, 25

▲ Outperform · 🎯$330

Price at call : $299.78 — upside +10%

Today : $316.33 — upside +4%

Expected +10% · Actual +9% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)

+9.4%

stock +9% · XLV +4%

UBS ↗

Apr 24, 25

▲ Buy · 🎯$330

Price at call : $299.78 — upside +10%

Today : $316.33 — upside +4%

Expected +10% · Actual +9% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)

+9.4%

stock +9% · XLV +4%

Apr 24, 25

▲ Buy · 🎯$330

Price at call : $299.78 — upside +10%

Today : $316.33 — upside +4%

Expected +10% · Actual +9% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 62% · +8.5% (92 calls)

+9.4%

stock +9% · XLV +4%

Stifel ↗

Apr 24, 25

▲ Buy · 🎯$318

Price at call : $299.78 — upside +6%

Today : $316.33 — upside +1%

Expected +6% · Actual +9% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 100% (1 call matured) · 📊 on Health : 47.2% · +12.4% (89 calls)

+9.4%

stock +9% · XLV +4%

Apr 24, 25

▲ Overweight · 🎯$315

Price at call : $298.25 — upside +6%

Today : $316.33 — upside -0%

Expected +6% · Actual +11% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 46% · +2.8% (126 calls)

+10.6%

stock +11% · XLV +5%

Baird ↗

Apr 24, 25

▲ Outperform · 🎯$325

Price at call : $298.25 — upside +9%

Today : $316.33 — upside +3%

Expected +9% · Actual +11% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 100% (1 call matured) · 📊 on Health : 48.6% · +2.9% (70 calls)

+10.6%

stock +11% · XLV +5%

Apr 11, 25

▲ Buy · 🎯$315

Price at call : $270.27 — upside +17%

Today : $316.33 — upside -0%

Expected +17% · Actual +23% · Reason (≥ +15%) : ✓ Yes

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 62% · +8.5% (92 calls)

+22.7%

stock +23% · XLV +7%

B of A Securities ↗

Mar 14, 25

▲ Buy · 🎯$320

Price at call : $272.62 — upside +17%

Today : $316.33 — upside +1%

Expected +17% · Actual +23% · Reason (≥ +15%) : ✓ Yes

🎯 on PEN : 100% (1 call matured) · 📊 on Health : 61.4% · +19.8% (83 calls)

+23.3%

stock +23% · XLV +4%

JP Morgan ↗

Feb 19, 25

▲ Overweight · 🎯$285

Price at call : $303.12 — upside -6%

Today : $316.33 — upside -10%

Expected -6% · Actual +12% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 100% (1 call matured) · 📊 on Health : 48.4% · +4.8% (126 calls)

+12.0%

stock +12% · XLV +7%

Feb 19, 25

▲ Buy · 🎯$325

Price at call : $303.12 — upside +7%

Today : $316.33 — upside +3%

Expected +7% · Actual +12% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 62% · +8.5% (92 calls)

+12.0%

stock +12% · XLV +7%

Feb 19, 25

▲ Outperform · 🎯$313

Price at call : $303.12 — upside +3%

Today : $316.33 — upside -1%

Expected +3% · Actual +12% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)

+12.0%

stock +12% · XLV +7%

Feb 19, 25

▲ Buy · 🎯$340

Price at call : $303.12 — upside +12%

Today : $316.33 — upside +7%

Expected +12% · Actual +12% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)

+12.0%

stock +12% · XLV +7%

UBS ↗

Feb 19, 25

▲ Buy · 🎯$320

Price at call : $303.76 — upside +5%

Today : $316.33 — upside +1%

Expected +5% · Actual +12% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)

+12.2%

stock +12% · XLV +7%

Feb 19, 25

▲ Overweight · 🎯$305

Price at call : $303.76 — upside +0%

Today : $316.33 — upside -4%

Expected +0% · Actual +12% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 46% · +2.8% (126 calls)

+12.2%

stock +12% · XLV +7%

Piper Sandler ↗

Feb 19, 25

▲ Overweight · 🎯$330

Price at call : $303.76 — upside +9%

Today : $316.33 — upside +4%

Expected +9% · Actual +12% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)

+12.2%

stock +12% · XLV +7%

Dec 18, 24

▲ Buy · 🎯$285

Price at call : $243.52 — upside +17%

Today : $316.33 — upside -10%

Expected +17% · Actual +30% · Reason (≥ +15%) : ✓ Yes

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 62% · +8.5% (92 calls)

+29.7%

stock +30% · XLV +14%

Dec 11, 24

▲ Overweight · 🎯$275

Price at call : $253.66 — upside +8%

Today : $316.33 — upside -13%

Expected +8% · Actual +23% · Reason (≥ +15%) : ✓ Yes

🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 46% · +2.8% (126 calls)

+22.8%

stock +23% · XLV +8%

Dec 9, 24

▲ Buy · 🎯$323

Price at call : $242.27 — upside +33%

Today : $316.33 — upside +2%

Expected +33% · Actual +25% · Reason (≥ +15%) : ✓ Yes

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)

+25.1%

stock +25% · XLV +6%

Nov 26, 24

▲ Buy · 🎯$270

Price at call : $244.15 — upside +11%

Today : $316.33 — upside -15%

Expected +11% · Actual +20% · Reason (≥ +15%) : ✓ Yes

🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 48.7% · +4.2% (39 calls)

+20.1%

stock +20% · XLV +7%

Piper Sandler ↗

Nov 20, 24

▲ Overweight · 🎯$250

Price at call : $240.49 — upside +4%

Today : $316.33 — upside -21%

Expected +4% · Actual +20% · Reason (≥ +15%) : ✓ Yes

🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)

+20.0%

stock +20% · XLV +7%

Nov 4, 24

▲ Buy · 🎯$260

Price at call : $229.51 — upside +13%

Today : $316.33 — upside -18%

Expected +13% · Actual +2% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 52.2% · +6.5% (90 calls)

+2.4%

stock +2% · XLV -1%

Piper Sandler ↗

Oct 31, 24

▲ Overweight · 🎯$235

Price at call : $233.3 — upside +1%

Today : $316.33 — upside -26%

Expected +1% · Actual -3% · Reason (≥ +15%) : ✗ No

🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)

-3.0%

stock -3% · XLV -2%